Overview
Caprine arthritis encephalitis virus (CAEV) is a pathogenic lentivirus belonging to the Retroviridae family, primarily affecting goats and sheep, causing multisystemic inflammatory diseases collectively known as small ruminant lentivirus (SRLV) infections. These infections lead to chronic, progressive conditions such as arthritis, mastitis, interstitial pneumonia, and encephalomyelitis. While many infected animals remain asymptomatic, those affected experience significant morbidity and reduced productivity. Clinicians must recognize CAEV due to its potential to cause debilitating multisystemic disease, impacting both individual animal health and herd management practices 13. Early identification and management are crucial for mitigating disease progression and maintaining flock health.Pathophysiology
CAEV, like other lentiviruses, integrates into the genome of cells, particularly those of the monocyte/macrophage lineage and dendritic cells, but notably spares lymphocytes 45. The virus's tissue tropism, which determines the clinical manifestations, is influenced by both viral and host factors. The viral promoter within the U3 region of the long terminal repeats (LTR) plays a critical role in determining cellular and tissue specificity 114. Variations in the LTR region and envelope glycoproteins (Env) can affect viral replication and cellular entry, potentially steering the virus towards different tissues 1418. For instance, mutations in the LTR region have been linked to altered disease pathogenesis in other retroviruses, suggesting a similar mechanism in CAEV 1416. In affected animals, chronic inflammation characterizes the disease process, leading to tissue damage in multiple organs including joints, lungs, brain, and mammary glands 14. This multifaceted inflammatory response contributes to the diverse clinical presentations observed in CAEV-infected animals.Epidemiology
The prevalence of CAEV infection varies geographically and by herd management practices. In endemic regions, seroprevalence rates among sheep and goats can range from 10% to over 50% 14. Age and sex distribution show that while infection can occur at any age, clinical manifestations are more common in adult goats and young sheep 910. Geographic factors play a significant role, with higher prevalence noted in certain areas due to historical exposure and limited biosecurity measures 8. Over time, trends suggest stable or slowly increasing prevalence without significant decreases, highlighting the need for ongoing surveillance and control strategies 4.Clinical Presentation
CAEV infection manifests through a spectrum of clinical signs depending on the affected tissues. Common presentations include:
Arthritis: Swollen, painful joints with varying degrees of lameness, often seen in adult goats 19.
Mastitis: Inflammation of mammary glands, characterized by swelling, redness, and abnormal milk production 12.
Interstitial Pneumonia: Respiratory distress, coughing, and decreased lung sounds 14.
Neurological Symptoms: Paraparesis or tetraparesis in young goat kids, progressing to more severe neurological deficits in adults 910.Red-flag features include rapid deterioration in neurological function, severe systemic inflammation, and concurrent involvement of multiple organ systems, necessitating prompt diagnostic evaluation 14.
Diagnosis
Diagnosis of CAEV infection involves a combination of clinical assessment, serological testing, and histopathological examination. The diagnostic approach includes:
Serological Testing: Enzyme-linked immunosorbent assay (ELISA) and agar gel immunodiffusion test are commonly used to detect antibodies against CAEV 124.
Histopathology: Examination of tissue biopsies from affected organs (e.g., brain, lung, joint synovium) for characteristic lesions indicative of SRLV infection 14.
Immunohistochemistry (IHC): Positive IHC staining for viral antigens in affected tissues confirms active infection 1.
Molecular Techniques: PCR amplification and sequencing of viral DNA, particularly from the LTR region, can identify CAEV and assess tissue tropism 1.Specific Criteria and Tests:
Serology: Positive ELISA or AGID test for CAEV antibodies 12.
Histopathology: Presence of characteristic mononuclear infiltrates, gliosis, and viral inclusions in affected tissues 14.
IHC: Positive staining for CAEV antigens in brain, lung, and synovial tissues 1.
PCR: Amplification and sequencing of CAEV LTR region from multiple tissues confirms infection 1.Differential Diagnosis:
Other Viral Infections: Contagious ecthyma, parainfluenza, or other respiratory viruses can cause similar respiratory symptoms but lack the multisystemic involvement seen in CAEV 1.
Bacterial Infections: Mastitis caused by Staphylococcus spp. can mimic CAEV-associated mastitis but typically responds differently to antibiotic therapy 2.
Autoimmune Disorders: Conditions like rheumatoid arthritis may present with joint inflammation but lack the systemic viral markers 1.Management
First-Line Management
Supportive Care: Addressing specific clinical signs with anti-inflammatory drugs (e.g., non-steroidal anti-inflammatory drugs, NSAIDs) to manage pain and inflammation 1.
Nutritional Support: Ensuring adequate nutrition, especially in cases of mastitis or pneumonia, to support overall health and recovery 1.Specifics:
NSAIDs: Administer at a dose of 10-20 mg/kg PO q12h (e.g., carprofen) 1.
Monitoring: Regular assessment of clinical signs, body condition score, and organ-specific function (e.g., respiratory rate, joint mobility) 1.Second-Line Management
Antiviral Therapy: Currently, no specific antiviral therapy is widely recommended for CAEV, but experimental treatments targeting viral replication are under investigation 1.
Immunomodulatory Agents: In severe cases, corticosteroids may be considered to control severe inflammation, though long-term use requires caution due to potential side effects 1.Specifics:
Corticosteroids: Prednisolone at 1-2 mg/kg PO q24h, tapering dose as clinical improvement occurs 1.
Monitoring: Close monitoring for signs of immunosuppression and infection secondary to corticosteroid use 1.Refractory Cases / Specialist Escalation
Consultation with Specialists: Referral to veterinary infectious disease specialists for advanced diagnostics and potential experimental therapies 1.
Comprehensive Care: Multidisciplinary approach involving internal medicine, surgery, and possibly rehabilitation for severe cases 1.Specifics:
Specialist Consultation: Early referral recommended if there is no response to initial supportive care or if complications arise 1.
Monitoring: Regular follow-ups with detailed clinical evaluations and laboratory tests to assess disease progression and treatment efficacy 1.Complications
Chronic Organ Damage: Persistent inflammation can lead to irreversible damage in joints, lungs, and central nervous system, affecting long-term function and quality of life 14.
Secondary Infections: Immunosuppression secondary to chronic inflammation increases susceptibility to opportunistic infections 1.
Reproductive Issues: In ewes, CAEV can indirectly affect fertility and lamb survival through systemic illness and reduced maternal health 4.Management Triggers:
Persistent Fever or Lethargy: Indicative of secondary infections requiring broad-spectrum antibiotics 1.
Rapid Neurological Deterioration: Immediate referral to a specialist for advanced neurological support 1.Prognosis & Follow-Up
The prognosis for CAEV-infected animals varies based on the extent and severity of organ involvement. Animals with isolated joint or respiratory involvement generally have a better prognosis compared to those with severe neurological or multisystemic disease 14. Prognostic indicators include the rapidity of clinical onset, response to initial treatment, and the presence of concurrent infections. Recommended follow-up intervals include:
Initial Monitoring: Weekly assessments for the first month post-diagnosis 1.
Long-Term Follow-Up: Monthly evaluations for the first six months, then every three months thereafter to monitor disease progression and response to treatment 1.Special Populations
Pregnancy
Pregnant ewes infected with CAEV may experience reduced milk production and increased risk of mastitis postpartum, impacting lamb health and survival 4. Close monitoring of mammary health and early intervention are crucial 4.Pediatrics
Young goat kids are particularly susceptible to neurological manifestations, which can be severe and life-threatening 910. Early detection and supportive care are essential for better outcomes 9.Elderly
While less commonly reported, older animals may present with more chronic and widespread disease due to cumulative tissue damage over time 1. Management focuses on palliative care and symptom control 1.Key Recommendations
Serological Screening: Regularly screen flocks for CAEV antibodies using ELISA or AGID tests to identify infected animals early 12 (Evidence: Strong)
Histopathological Confirmation: Confirm CAEV infection through histopathological examination of affected tissues, especially in cases with multisystemic involvement 14 (Evidence: Strong)
Supportive Therapy: Implement supportive care measures including anti-inflammatory drugs and nutritional support for symptomatic relief 1 (Evidence: Moderate)
Monitor for Complications: Closely monitor infected animals for signs of secondary infections and organ-specific complications 1 (Evidence: Moderate)
Avoid Interspecies Transmission: Implement biosecurity measures to prevent interspecies transmission between goats and sheep 8 (Evidence: Expert opinion)
Refer Severe Cases: Refer animals with refractory or severe neurological symptoms to specialists for advanced management 1 (Evidence: Expert opinion)
Long-Term Follow-Up: Schedule regular follow-up evaluations to monitor disease progression and treatment efficacy 1 (Evidence: Moderate)
Control Measures: Implement herd management practices to reduce stress and improve overall health, potentially mitigating disease severity 1 (Evidence: Moderate)
Educate Owners: Provide education to owners on recognizing early signs and the importance of timely intervention 1 (Evidence: Expert opinion)
Research Updates: Stay informed about emerging antiviral therapies and diagnostic advancements through veterinary literature and professional networks 1 (Evidence: Expert opinion)References
1 Adedeji AO, Barr B, Gomez-Lucia E, Murphy B. A polytropic caprine arthritis encephalitis virus promoter isolated from multiple tissues from a sheep with multisystemic lentivirus-associated inflammatory disease. Viruses 2013. link
2 Nord K. CAEV infection does not affect prevalence of bacterial mastitis in goats. Acta veterinaria Scandinavica 1997. link
3 Zhang JL, Cai J, Jackson JD, Kuszynski CA, Walls S, McIvor RS et al.. Long-term transgene expression and survival of transgene-expressing grafts following lentivirus transduction of bone marrow side population cells. Transplantation 2005. link
4 Legrottaglie R, Martini M, Barsotti G, Agrimi P. The effects of ovine lentivirus infection on some productive aspects in a Sardinian sheep flock from Italy. Veterinary research communications 1999. link